BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Daniel Stauder does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ATRCAtriCure Inc | Buy | $60.00 | Apr 2025 | −12.8% | Miss |
| ATRCAtriCure Inc | Buy | $60.00 | Apr 2025 | −16.1% | Miss |
 STIMNeuronetics Inc | Buy | $7.00 | Mar 2025 | −76.5% | Miss |
 LMATLeMaitre Vascular Inc | Buy | $110.00 | Feb 2025 | +9.8% | Hit |
| ATRCAtriCure Inc | Buy | $60.00 | Feb 2025 | −31.1% | Miss |
| ATRCAtriCure Inc | Buy | $60.00 | Feb 2025 | −17.0% | Miss |
| LMATLeMaitre Vascular Inc | Buy | $100.00 | Aug 2024 | +22.1% | Hit |
| LMATLeMaitre Vascular Inc | Buy | $77.00 | May 2024 | +8.8% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.